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The role of diet in the development of breast cancer: a case-control study
of patients with breast cancer, benign epithelial hyperplasia and
fibrocystic disease of the breast
D.M. Ingram, E. Nottage & T. Roberts
Queen Elizabeth II Medical Centre, Perth, Western Australia 6009.
Summary A case-control study was undertaken to investigate the role of diet in women with breast cancer,
and in two groups of women with benign breast disease: epithelial hyperplasia, and fibrocystic disease without
hyperplasia.
The study provides data which suggest that the consumption of red meat, savoury meals (pizza, pies, stew,
etc.) and of starches is disadvantageous, while the consumption ofchicken and fish, and of fruit, appears to be
beneficial. These patterns were present for both the breast cancer patients and the patients with benign
epithelial hyperplasia.
One-third of breast cancer patients had changed their diet after their diagnosis, compared to only around
12% in controls and patients with benign breast disease. Overall, the women studied had changed their diet to
reduce their intake of sugars, dairy products and meat, and increased their intake of poultry, fish, fruit and
vegetables over the past decade; but the breast cancer group was less likely to have made this change.
Before we can devise ways of preventing breast cancer from
developing, causative factors must be identified. Of those
identified to date, diet has aroused the greatest interest and
debate because of its potential for preventing breast cancer.
The early international correlation studies clearly associ-
ated animal fat consumption with breast cancer mortality
(Armstrong & Doll, 1975), yet case-control studies have, on
the whole, failed to confirm that a diet rich in fat increases
the risk of developing breast cancer (Goodwin & Boyd,
1987). There are a number of reasons why case-control
studies may not detect differences in diet between breast
cancer patients and their controls, if such differences do in
fact exist. Amongst them is the likelihood that any influence
of nutrition on the breast to increase its susceptibility to
cancer probably takes place a decade or more before the
breast cancer becomes clinically apparent (Ingram, 1981),
and in the intervening period the patient's dietary habits may
have changed.
In an attempt to overcome this problem, we have under-
taken a case-control study which includes not only breast
cancer patients and their controls, but also a group at in-
creased risk of developing breast cancer, women with benign
epithelial hyperplasia of the breast (BEH). Hyperplasia of the
breast epithelium has been identified as a change which
probably precedes breast malignancy (Dupont & Page, 1985),
and although the time interval is uncertain, it is likely to be
at least a decade. In addition, patients at low risk of develop-
ing breast cancer, women with benign fibrocystic disease of
the breast without histological evidence of hyperplasia
(FCD), were studied as a control group, as well as a group of
community controls. If nutrition were to play a part in breast
cancer development, one would expect the dietary intake of
the low-risk group (FCD) to differ little from controls, while
that of the higher-risk group (BEH) would show differences
which might give an insight into dietary habits long before
breast cancer had developed, and into how diet may influence
the very early stages of breast cancer development.
Method
Study population
Five hundred and fourteen women were studied in the period
February 1985 to August 1987. Cases were identified from
the pathology records at the Queen Elizabeth II Medical
Centre, Perth, Western Australia, and were contacted after
first gaining the approval of their surgeons. The histo-
pathology of each case was reviewed by a single pathologist
(A.R.), who categorised the cases into invasive breast cancer
(IBC), BEH or FCD according to set criteria. Patients with
other pathologies were not included. Controls were identified
from the electoral roll, and were contacted in the same
manner as cases, by way of a letter requesting their participa-
tion in a health survey, but without specific mention of breast
disease. If the letter was not answered, it was followed by a
telephone call. None of the patients and only 5.5% of con-
trols could not be contacted. All breast cancer patients, 78%
of benign breast disease patients, and 78% of contactable
controls, agreed to participate in the study.
Of the 514 women who initially agreed to participate, 99
breast cancer patients, 91 patients with benign epithelial
hyperplasia, 95 patients with fibrocystic disease and 209 con-
trols were included in the study. Twenty subjects were
excluded from the study: two died before data could be
collected, one was pregnant, ten withdrew for personal
reasons, and in seven instances the dietary questionnaire was
so incomplete as to be not usable, even after further attempts
to complete it.
Cases were matched to controls by age (5-year age group)
and area of residence (electoral district). Where possible,
more than one control was used for each case. In addition,
the patients with fibrocystic disease were matched to those
with benign epithelial hyperplasia, so these groups shared the
same controls.
Interview
A structured intervew was conducted in the subject's home
by a single interviewer (E.N.), 3 months after their operation.
Although the interviewer was blind to the diagnosis, in the
course of the interview it would often become apparent
which were the breast cancer patients.
Data were collected as regards age, menstrual status,
ethnic origin, occupation, risk factors for breast cancer,
previous breast disease, other major illnesses and medica-
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tions. Each woman was asked whether her diet had changed
for any reason in the past 3 months. In addition, each was
asked how her eating patterns had changed over the past 10
years, asking specifically regarding consumption of red
meats, poultry and fish, saturated fats, polyunsaturated fats,
fruit and vegetables, dairy products, cereal products, sugars
and prepared or convenience foods. Height and weight were
measured using the same set of scales.
After explanation and demonstration of standard portion
sizes, each subject was requested to complete a food fre-
quency questionnaire, based on current consumption, in their
own time and return it by mail. Any problems were resolved
per telephone. The food frequency questionnaire has been
tested previously, and came with a commerical analysis
package (FREQUAN, the Division of Human Nutrition,
Commonwealth Scientific and Industrial Research Organis-
ation, South Australia) (Baghurst & Record, 1984). This
program identifies 179 different foods, and analysis is based
on both portion size and frequency of consumption. The
program generates a breakdown of consumption of nutrients
as well as the consumption of the main food groups. In
addition, the proportion of total energy derived from each of
the major nutrients was calculated.
Statistical analysis
Quartiles for each nutrient and food group were derived
from the control populations, and the odds ratio and 95%
confidence limits determined by conditional logistic regres-
sion. These were determined both for quartiles and at the
median level of consumption. Significant associations were
recalculated after adjusting for known risk factors for breast
cancer: parity, first-degree family history of breast cancer,
age at menarche and body mass index.
The mean consumption of each nutrient and food group
were calculated for each patient group and their control.
Means were compared by one-way analysis of variance.
Results
Study population (Table I)
A comparison of patient and control characteristics and risk
factors for each of the study groups is shown in Table I. The
only significant differences between cases and controls were
for family history and indices of obesity. Nineteen per cent of
cancer patients had a first-degree relative with breast cancer,
compared with 8.7% of the controls (P<0.05). Ten per cent
of BEH patients had a positive family history of breast
cancer, compared with 6% of controls, but this did not reach
significance. BEH patients weighed less and had a lower
body mass index than controls. These results have been
presented and discussed previously (Ingram et al., 1989). The
breast cancer patients' lower parity when compared with
controls, and their lower age at menarche, did not reach
statistical significance.
Estimations ofrisk (Table II)
After estimation of the odds ratio for consumption of each
nutrient, the only significant finding was for the proportion
of energy derived from sugar, this being protective for benign
epithelial hyperplasia. When examined by quartiles, an addi-
tional significant finding was of a protective effect for vitamin
C consumption, with fibrocystic disease in the highest quar-
tile of consumption (O.R 0.4, c.l. 0.1-0.9). An increase in
risk was demonstrated, however, for both the cancer and
benign epithelial groups for starch consumption (cancer O.R.
2.0, c.l. 0.9-4.4; BEH O.R. 2.1, c.l. 0.9-4.7), and for mono-
unsaturated fat consumption (cancer O.R. 1.9, c.l. 0.8-4.2;
BEH O.R. 2.3, c.l. 0.9-6.3) for the highest quartiles of
consumption. These did not quite reach significance.
Analysis of consumption of food groups demonstrated
that, for the cancer patients, there was a significant increase
in risk with consumption of red meats and savoury snacks;
for the BEH patients, a protective effect for consumption of
eggs, chicken and seafood; while the FCD group also demon-
strated the protective effect of egg consumption. When con-
sidering the highest quartile of food consumption, additional
significant findings were of a reduced risk in the BEH group
with consumption of fruit (O.R. 0.4, c.l. 0.2-0.9) and leafy
and orange-red vegetables (O.R. 0.4, c.l. 0.2-0.9), and also
for the consumption of yellow-orange fruit in the FCD group
(O.R. 0.4, c.l. 0.1-0.9).
The significant associations were recalculated after adjust-
ing for possible confounding variables. The previously signi-
ficant elevated odds ratios for red meat and for snacks (Table
HIc) fell to just below significant levels. Other significant odds
ratios were not affected.
Comparison of mean consumption between cases and controls
(Table III)
Cancer patients had significantly greater consumption of
retinol, red meats and savoury foods compared to controls.
The BEH patients similarly consumed more savoury foods,
but this did not reach significance.
Patients with benign epithelial hyperplasia consumed signi-
ficantly more starches, both when calculated as actual con-
sumption and when calculated as a proportion of total
energy consumption. The cancer patients similarly consumed
more starches, but again not quite reaching statistical signi-
ficance. The increase in starch consumption appeared to
come from the increased consumption of starchy vegetables.
Benign epithelial hyperplasia patients consumed signifi-
cantly less chicken and seafood and less fruit than controls.
Again, similar patterns of consumption are seen for the
cancer patients, but also not quite to a significant level.
The fibrocystic group were found to consume significantly
less vitamin C and yellow-orange fruit than controls, and
more polyunsaturated fats.
Change in diet (Tables III and IV)
As there was concern that a recent diagnosis of breast cancer
might have influenced a subject's diet, all subjects were asked
Table I Comparison of breast cancer risk factors for cases and controls
Group
Benign
Breast Cancer epithelial Fibrocystic Benign
cancer control hyperplasia disease control
Age (years) (mean± s.e.m.) 55.9± 1.3 55.5± 1.3 43.5± 1.1 43.3± 1.0 43.7± 1.0
Age range (years) 25-86 22-86 19-72 19-71 20-72
Parity (number children) 2.50±0.1 2.55±0.1 2.41 ±0.1 2.30±0.1 2.43±0.1
First-degree family history (%) 19.0± 3.9a 8.7±2.4 10.0± 3.1 7.3±2.6 6.0±2.1
Weight (kg) 64.9± 1.1 64.2± 1.2 62.1±.-Oa 63.8± 1.2 65.6± 1.4
Body mass index (kg m-2) 25.82±0.5 25.46±0.4 23.45±0.4b 24.09±0.4 25.2±0.4
Age at menarche (years) 13.02±0.1 13.42±0.1 13.10±0.1 13.12±0.1 13.23±0.1
Age at menopause (years) 48.24±0.7 48.73±0.7 48.88± 1.6 50.4± 1.4 46.3±2.1
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Table II Estimation ofodds ratio and 95% confidence limits for consumption ofnutrients and food groups foreach ofthe
patient groups studied
Breast cancer
excluding diet Benign epithelial
Breast cancer change subjects hyperplasia Fibrocystic disease
Nutrient O.R. 95% CI O.R. 95% CI O.R. 95% CI O.R. 95% CI
A. Actual consumption
Total energy 1.1
Total carbohydrates 1.5
sugar 1.1
starches 1.5
Total protein 1.4
Total fats 1.4
saturated 1.0
monounsaturated 1.6
polyunsaturated 0.9
Fibre 1.5
Vitamins
Retinol 1.0
Betacarotene 0.8
Bi 1.2
B6 1.3
C 1.5
B. Consumption as a proportion oftotal energy
Sugars 1.0
Starches 1.4
Protein 0.6
Total fat 1.3
saturated 1.0
monounsaturated 1.4
polyunsaturated 0.6
0.9
0.7
1.3
0.9
1.0
1.2
1.6
1.8
0.9
1.7
0.9
2.0
0.9
1.1
1.0
1.4
1.0
0.9
C. Food group
Cereal products
Cakes, desserts, sweets, jam, etc
Dairy products (total)
Milk and milk products
Eggs
Butter and margarine
Meat (total)
Red meats
Chicken and seafood
Savoury foods (total)
Meals, e.g. pizza, stew, pies, etc.
Snacks, e.g. crisps, nuts, biscuits
Fruit (total)
Yellow and orange fruit
Other fruit
Vegetables (total)
Leafy and orange/red vegetables
Starchy vegetables
Estimates are based on the median consumption ofeach nutrient by control subjects. ap<0.05; bp<0.01.
whether their diet had changed for any reason over the past 3
months. Around one-third of cancer patients admitted to
recent dietary change, while only little more than 10% of
patients with benign biopsies and controls admitted to
change in diet (Table IV).
As there was a considerable difference between the number
of cancer patients and their controls who had changed their
diet recently, the statistics were recalculated for these groups
after exclusion of those who had changed their diet (Table
III). This reanalysis resulted in consumption of starches
(O.R. 2.0) and of monounsaturated fats (O.R. 2.3) from the
nutrient analysis, and of butter and margarine (O.R. 2.3) and
mean (O.R. 2.0) from the food group analysis, now becom-
ing significant variables (Table II). Reanalysis of the mean
consumption (Table III) had little effect on the overall
results, but did increase the mean consumption of fats and
reduce the mean consumption of fibre and vitamins for the
cancer patients. These changes were also seen in the food
group analyses where the mean consumption of cakes etc.,
butter and margarine, meat and savoury meals increased and
the consumption of fruit decreased.
In addition, each woman was asked how her eating pat-
terns had changed over the past 10 years (Table V). In
general, the trend was towards eating less red meat, saturated
fat, dairy products and sugars, and more poultry and fish,
unsaturated fats and fruit and vegetables. Although there
was little difference between the cancer patients and other
groups in these trends, for every food group the cancer
patients were more likely to have scored 'no change' in their
diet over the past 10 years.
Discussion
The results of studies to date investigating associations
between diet and breast cancer are inconsistent. The original
concept that diet, and particularly dietary fat, might be
related to breast cancer development came from international
correlation studies. All have demonstrated significant positive
correlations between fat intake and breast cancer mortality.
A strong correlation, however, does not mean that the assoc-
iation is causal. Fat intake is, in general, an indicator of
affluence, and there are many other differences apparent
between countries with a high and low breast cancer mortal-
ity. National or regional studies have, for the most part, also
shown a significant positive correlation between fat intake
and breast cancer mortality.
With case-control studies, very few have found significant
associations between dietary fat and breast cancer risk,
although a number of studies identified consumption of fat-
containing foods such as meat, butter and margarine, and
breast cancer risk. Goodman and Boyd (1987) published a
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Table III Mean (+s.e.m.) consumption of nutrients and food groups for each study group and their controls
Breast cancer Benign
Breast excluding diet Cancer epithelial Fibrocystic Benign
Nutrient Unit cancer change subjects control hyperplasia disease control
A. Actual consumption
Total energy kJ 8316±271 8411 ±322 8022±217 8592±324 8142±268 8218±224
Total carbohydrate g day-' 225±8 221 ± 10 218 ±7 238± 12 223±8 228± 7
sugars gday-' 124±6 121±7 126±5 135±10 129±6 135±6
starches gday-' 100±4.0 100±5 91±3.1 103±4a 93±4 92±3
Total protein g day-' 84±3 85 ± 3 83±2 85 +3 83 +2 85+2
Total fats gday-' 72.1±2.8 75.2±3.3 69.0±2.3 75.7±3.2 70.7±2.9 70.6±2.5
saturated g day-' 31.4±1.5 33.4± 1.8 29.7±1.2 32.6±1.7 29.3±1.3 30.6±1.3
monounsaturated g day- 27.2± 1.1 28.3 ± 1.2 25.6± 0.9 28.3± 1.2 26.2± 1.1 26.4± 0.9
polyunsaturated g day-' 13.5±0.7 13.4±0.7 13.7±0.6 14.8±0.7 15.2±0.9 13.6±0.5
Fibre g day-' 26.9± 1.1 24.5± 1.0 25.6± 1.0 25.4± 1.1 24.2±0.9 26.6± 1.0
Vitamins
Retinol unit day-' 931 ± 120a 849± 127 652± 75 662± 83 792±95 683±86
Betacarotene jig day-' 7772±464 7370±482 7356± 351 7403±497 7232± 395 8076±433
BI mg day- 1.41± 0.05 1.33 ±0.05 1.31± 0.04 1.34±0.05 1.29±0.04 1.37±0.04
B6 mg day-' 1.81±0.06 1.74±0.06 1.72±0.05 1.71±0.06 1.71±0.05 1.79±0.05
C mg day-' 174± 8.7 162±9 162±8.6 159±9 149± 6b 184± 10
B. Consumption as a proportion oftotal energy
Sugars % 24.0±0.7 23.0±0.9 25.1 ±0.7 23.8±0.9 25.6± 0.8 26.4±0.8
Starches % 19.3±0.4 19.0±0.5 18.3±0.4 19.8±0.6b 18.3±0.4 17.9±0.4
Protein % 17.6±0.3 17.4±0.4 17.9±0.3 17.3±0.3 17.7±0.3 18.0±0.3
Fats % 31.6±0.6 32.8 ±0.6 31.6±0.5 32.4±0.6 31.6±0.6 31.3±0.5
saturated % 13.6±0.4 14.4±0.4 13.5±0.3 13.7±0.4 13.1 ±0.3 13.4±0.3
monounsaturated % 12.0±0.2 12.4±0.3 11.8±0.2 12.1 ±0.2 11.7±0.2 11.7±0.2
polyunsaturated % 6.09±0.25 6.0±0.3 6.33± 0.21 6.62±0.25 6.78 0.27a 6.16±0.19
C. Food group
Cereal products g day-' 71.6± 3.6 68.9±4.2 68.4± 2.8 73.5 ± 3.5 67.8 3.7 66.1 ±2.9
Cakes, desserts, sweets, jam, etc g day-' 46.5±4.6 52.2± 6.2 54.8± 5.4 54.7± 8.4 41.4±4.0 49.5± 5.3
Dairy products (total) g day-' 65.2± 3.6 64.8±4.5 65.6± 2.9 70.1 ±4.9 68.9± 3.0 67.6±2.9
Milk and milk products g day 47.4 ± 3.2 46.0±4.0 48.9 ± 2.6 52.9±4.5 53.2± 2.9 51.1 ± 2.6
Eggs g day-' 4.9±0.5 5.5±0.6 4.5±0.4 4.4±0.6 4.1±0.4 4.8±0.4
Butter and margarine g day-' 12.9±0.8 13.4±0.9 12.3±0.7 12.8±0.9 11.6± 1.0 11.6±0.7
Meat (total) g day- 56.5 ±2.7 58.0± 1.8 52.6±2.0 53.4±2.5 54.1 ±2.4 55.1 ±2.0
Red meats gday-' 41.4±2.6' 43.5±2.8a 35.3± 1.7 39.7±2.5 39.0±2.3 38.4± 1.8
Chicken and seafood g day' 15.1±0.8 15.6± 1.1 17.3± 1.0 13.7±1.0a 15.1 ± 1.1 16.6± 1.0
Savoury foods (total) gday-' 48.2±3.la 47.8±3.7a 39.8±2.3 49.6± 3.2 42.4±2.6 44.4±2.5
Meals, e.g. pizza, stew, pies, etc g day- 34.9 ±2.8 36.3 ± 3. a 29.7± 1.8 39.4± 3.0 32.8 ± 2.0 33.1 ± 1.9
Snacks,e.g.crisps,nuts,biscuits gday-' 13.3±1.8 11.4±1.8 10.1±1.1 10.2±1.3 10.6±1.3 11.4± 1.2
Fruit (total) gday-' 51.7±3.5 45.1±4.6 54.1±3.7 44.9±3.7a 48.7±3.4 58.2±4.7
Yellow and orange fruit g day-' 19.8±2.0 22.1 ± 1.8 19.3± 1.7 17.3± 1.7 14.8±1.2a 20.8± 1.9
Other fruit gday-' 31.9±2.3 26.7±2.4 34.8±2.5 27.5±2.4a 33.9±2.9 37.3± 3.7
Vegetables (total) g day-' 55.1 ± 3.1 55.3 ± 3.7 49.5± 2.1 55.6± 2.8 52.7± 3.0 52.4± 1.8
Leafy and orange-red vegetables g day-' 22.0±1.5 22.1 ± 1.8 19.8±1.1 19.1 ± 1.4 20.0±1.3 21.9±1.1
Starchy vegetables g day 33.1 ± 2.3 33.2± 2.7 29.7± 1.5 36.5± 2.Sa 32.7± 2.1 30.5± 1.4
P< 0.05; bp<O,Ol1
Table IV Proportion of study subjects who stated they had changed
their diet in the past 3 months
Benign
Breast Cancer epithelial Fibrocystic Benign
cancer controls hyperplasia disease controls
Changed 32% 11% 13% 12% 11%
diet
No change 68% 89% 87% 86% 89%
in diet
Table V Change in diet over the past decade
Now eat less No change Now eat more
Total Cancer Total Cancer Total Cancer
group patients group patients group patients
Cereal products 20% 16% 64% 71% 16% 13%
Sugars 47% 34% 52% 63% 1% 3%
Dairy products 31% 23% 64% 71% 5% 6%
Saturated fats 47% 40% 51% 60% 2% 0%
Polyunsaturated 14% 5% 56% 67% 30% 28%
fats
Red meat 59% 50% 37% 45% 4% 5%
Poultry/fish 6% 9% 45% 50% 49% 41%
Prepared/con- 15% 14% 70% 78% 15% 18%
venience food
Fruit and 3% 2% 59% 70% 38% 28%
vegetables
Thebreastcancerpatientswerearound 10% less likely to havemadea
change in their diet.
detailed critical analysis of all studies published on the sub-
ject to that time. Howe et al. (1990) have recently conducted
a combined analysis of the original data from 12 case-control
studies. Their results show a consistent, statistically signifi-
cant, positive association between breast cancer risk and
saturated fat consumption in postmenopausal women, the
relative risk for highest vs lowest quintiles being 1.46
(P<0.0001). In addition, a consistent protective effect for a
number of markers of fruit and vegetable intake was demon-
strated. For Vitamin C, the relative risk of highest vs lowest
quintile was 0.69 (P<0.0001).
At odds with these results are those of the two large North
American cohort studies. A study of 89,538 nurses by Willett
et al. (1987) and of 5,485 women by Jones et al. (1987) failed
to find any evidence of a positive association between breast
cancer risk and fat intake. Indeed, the relative risk for the
highest vs lowest quintile of saturated fat in postmenopausal
women was only 0.79 in Willett's study, and similarly Jones'
study showed an apparent protective effect of high fat intake.
To resolve the discrepancy in results between these cohort
studies and the case-control studies and correlation studies,
further analytic epidemiological data need to be acquired.
A number of findings of interest have arisen from the
study. The consumption of starches, particularly from vege-
tables, appeared to be disadvantageous, and is seen in both
the BEH and cancer groups. Such a finding is difficult to
explain, and no mechanisms is apparent. The consumption of
savoury foods such as pizzas, stews, etc and the consumptionTHE ROLE OF DIET IN BREAST CANCER DEVELOPMENT 191
of red meat appeared to be detrimental, while the consump-
tion of chicken and seafood were beneficial. In general, these
findings are also present in both the BEH and cancer groups.
Unfortunately, the dietary analysis program does not allow
separation of the poultry and fish groups so that the appar-
ent beneficial effect of these could be explored further. The
above findings would suggest that the type of fat consumed
may be important; however, in the analysis by breakdown
into nutrients, it is only the consumption of monoun-
saturated fats which differs between cases and controls, and
then only at the highest quartile of consumption.
The consumption of fruit appears to be beneficial, again
these findings being apparent for both the BEH and the
breast cancer groups. Presumably this beneficial effect is
through anti-oxidants in the food, but surprisingly no signifi-
cant differences for beta-carotene or vitamin C are seen
between cases and controls, although the BEH group does
have a considerably lower consumption of these than the
controls. As hypothesised, only occasional significant associa-
tions were seen for the FCD group, and in general consump-
tion of nutrients and food groups were similar to the
controls.
If recommendations were to be made from these data as to
a diet which might help reduce the incidence of breast cancer,
they would be similar to those of the generally promoted
'healthy' diet of a reduced consumption of red meats and
prepared foods, and an increased consumption of poultry,
fish, fruit and vegetables. It is of note that, while the data in
Table V suggests that the populace is already moving
towards such a diet, the women in the breast cancer group
were the least likely to have made changes over this time.
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